I have been at The Cancer Institute of New Jersey (CINJ) since 2004 after completing a fellowship in hematology/oncology at UMDNJ-Robert Wood Johnson Medical School-The Cancer Institute of New Jersey which was preceded by an internal medicine residency at Robert Wood Johnson University Hospital.
While I have a clinical focus on multiple myeloma and stem cell transplantation, I also evaluate patients with leukemia, lymphoma, and other blood cancers. Along with assistance from the multidisciplinary teams within the Leukemia/Lymphoma/Hematologic Malignancies and Stem Cell Transplantation Programs at CINJ, I help educate patients on their treatment options so that they can make an informed decision.
I have a strong research interest in early drug development for patients with hematologic malignancies and am currently exploring new drugs for patients with multiple myeloma in collaboration with basic scientists. And by having the resources available that can only be found at a National Cancer Institute-designated Comprehensive Cancer Center, our team is able to translate these research findings and directly apply them to patient therapies.
I am an investigator on a number of clinical trials and the author or co-author of a number of publications with the goal of finding more effective and safer therapies for patients. As a patient advocate, I believe in a team approach to the care that I provide to help patients and their families with their diagnosis and treatments with a strong focus in education.
Multiple myeloma, stem cell transplantation, hematologic malignancies, leukemia and lymphoma
- New Jersey Commission on Cancer Research (NJCCR) Grant: “ Allogeneic Cellular Therapy For Hematologic Cancers” 2009 – 2011.
- The Melvyn H. Motolinsky Fellow Award, 2003
To schedule an appointment call 732-235-8515